Allstate to Report Q1 Earnings: Can Higher Premiums Save the Day?

29.04.25 18:08 Uhr

Werte in diesem Artikel
Aktien

173,10 EUR 2,55 EUR 1,50%

Indizes

PKT PKT

16.418,3 PKT 118,0 PKT 0,72%

5.560,8 PKT 32,1 PKT 0,58%

Property and casualty insurance provider The Allstate Corporation ALL is set to report its first-quarter 2025 results on April 30, 2025, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $2.27 per shareon revenues of $17.13 billion. (See the Zacks Earnings Calendar to stay ahead of market-making news.)The first-quarter earnings estimate declined 37.3% over the past 60 days. The bottom-line projection indicates a year-over-year decline of 55.8%. However, the Zacks Consensus Estimate for quarterly revenues suggests a year-over-year increase of 11%. Image Source: Zacks Investment ResearchFor 2025, the Zacks Consensus Estimate for Allstate’s revenues is pegged at $69.45 billion, implying a rise of 7.95% year over year. However, the consensus mark for 2025 EPS is pegged at $16.75, implying an 8.6% year-over-year fall.Allstate has a robust history of surpassing earnings estimates, beating the consensus estimate in each of the last four quarters, with the average surprise being 127.1%. This is depicted in the figure below.The Allstate Corporation Price and EPS Surprise The Allstate Corporation price-eps-surprise | The Allstate Corporation QuoteQ1 Earnings Whispers for AllstateOur proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.ALL has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.You can see the complete list of today’s Zacks #1 Rank stocks here.What’s Shaping Allstate’s Q1 Results?The Zacks Consensus Estimate and our model estimate for net premiums earned indicate 11.4% and 9.4% year-over-year growth, respectively. Net investment income is expected to have received an impetus from higher-yielding fixed-income securities. The Zacks Consensus Estimate for net investment income indicates 7.5% year-over-year growth from $764 million.The Zacks Consensus Estimate for adjusted net income from the Protection Services business indicates 19.6% year-over-year growth. The consensus mark for Homeowners’ policies in force indicates a 2.5% year-over-year increase.The consensus mark for underwriting income from the Auto brand is pegged at $525.5 million compared with $351 million a year ago. The combined ratio in this line of business is pegged at 94.64%, improving from 96% in the year-ago quarter. This means a larger portion of premiums remained in the company’s kitty following claim payments.The consensus estimate for underwriting loss from Commercial Lines is pegged at $29 million, down from $70 million a year ago. However, the consensus mark for adjusted net income from theAllstate Health and Benefits unit indicates a 26.8% year-over-year decrease. Ourmodel estimate for total costs and expenses indicates more than a 12% year-over-year increase due to higher operating costs and claims expenses, offsetting the positives.Stocks That Warrant a LookWhile an earnings beat looks uncertain for Allstate, here are some companies from the broader Finance space that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around:Lemonade, Inc. LMND has an Earnings ESP of +3.40% and is a Zacks #3 Ranked player.The Zacks Consensus Estimate for Lemonade’s bottom line for the to-be-reported quarter has witnessed one upward revision over the past 60 days against no movement in the opposite direction. The consensus estimate for Lemonade’s revenues for the to be reported quarter indicates 20.9% increase from a year ago.Trupanion, Inc. TRUP has an Earnings ESP of +220.00% and a Zacks Rank of 3.The Zacks Consensus Estimate for Trupanion’s bottom line for the to-be-reported quarter indicates a 68.8% year-over-year improvement. Trupanion beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 37.5%.Arthur J. Gallagher & Co. AJG has an Earnings ESP of +0.53% and a Zacks Rank of 3.The Zacks Consensus Estimate for Arthur J. Gallagher’s bottom line for the to-be-reported quarter signals a 2.3% increase from a year ago. Arthur J. Gallagher beat earnings estimates in three of the past four quarters and met once, with an average surprise of 2.3%.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Allstate Corporation (ALL): Free Stock Analysis Report Arthur J. Gallagher & Co. (AJG): Free Stock Analysis Report Trupanion, Inc. (TRUP): Free Stock Analysis Report Lemonade, Inc. (LMND): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Allstate und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Allstate

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Allstate

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Allstate Corp.

Wer­bung

Analysen zu Allstate Corp.

DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
03.04.2017Allstate Mkt PerformFBR & Co.
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
DatumRatingAnalyst
15.01.2019Allstate BuyCompass Point
11.08.2017Allstate OverweightBarclays Capital
09.05.2016Allstate BuyDeutsche Bank AG
10.08.2015Allstate BuyDeutsche Bank AG
04.08.2015Allstate OverweightBarclays Capital
DatumRatingAnalyst
03.04.2017Allstate Mkt PerformFBR & Co.
05.08.2015Allstate NeutralCompass Point
04.08.2015Allstate Sector PerformRBC Capital Markets
07.05.2015Allstate NeutralCompass Point
31.10.2014Allstate NeutralCompass Point
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Allstate Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen